127 related articles for article (PubMed ID: 17064686)
1. Cholesterol depletion reduces serotonin binding and signaling via human 5-HT(7(a)) receptors.
Sjögren B; Hamblin MW; Svenningsson P
Eur J Pharmacol; 2006 Dec; 552(1-3):1-10. PubMed ID: 17064686
[TBL] [Abstract][Full Text] [Related]
2. Depletion of the lipid raft constituents, sphingomyelin and ganglioside, decreases serotonin binding at human 5-HT7(a) receptors in HeLa cells.
Sjögren B; Svenningsson P
Acta Physiol (Oxf); 2007 May; 190(1):47-53. PubMed ID: 17428232
[TBL] [Abstract][Full Text] [Related]
3. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
Krobert KA; Andressen KW; Levy FO
Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
[TBL] [Abstract][Full Text] [Related]
4. Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors.
Mahé C; Loetscher E; Feuerbach D; Müller W; Seiler MP; Schoeffter P
Eur J Pharmacol; 2004 Jul; 495(2-3):97-102. PubMed ID: 15249157
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 affects serotonin binding and cell surface levels of human 5-HT7(a) receptors.
Sjögren B; Svenningsson P
FEBS Lett; 2007 Oct; 581(26):5115-21. PubMed ID: 17936759
[TBL] [Abstract][Full Text] [Related]
6. Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells.
Mahé C; Loetscher E; Dev KK; Bobirnac I; Otten U; Schoeffter P
Neuropharmacology; 2005 Jul; 49(1):40-7. PubMed ID: 15992579
[TBL] [Abstract][Full Text] [Related]
7. Site-directed mutagenesis of the 5-HT1B receptor increases the affinity of 5-HT for the agonist low-affinity conformation and reduces the intrinsic activity of 5-HT.
Grånäs C; Nordquist J; Mohell N; Larhammar D
Eur J Pharmacol; 2001 Jun; 421(2):69-76. PubMed ID: 11399261
[TBL] [Abstract][Full Text] [Related]
8. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
9. Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling.
Mialet J; Dahmoune Y; Lezoualc'h F; Berque-Bestel I; Eftekhari P; Hoebeke J; Sicsic S; Langlois M; Fischmeister R
Br J Pharmacol; 2000 Jun; 130(3):527-38. PubMed ID: 10821780
[TBL] [Abstract][Full Text] [Related]
10. Stimulating DDX3 expression by serotonin 5-HT receptor 7 through phosphorylation of p53 via the AC-PKA-ERK signaling pathway.
Kang LJ; Nguyen KVA; Eom S; Choi YJ; Nguyen CN; Lee J; Kim C; Lee S; Lee SG; Lee JH
J Cell Biochem; 2019 Oct; 120(10):18193-18208. PubMed ID: 31172579
[TBL] [Abstract][Full Text] [Related]
11. Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors.
Egan C; Grinde E; Dupre A; Roth BL; Hake M; Teitler M; Herrick-Davis K
Synapse; 2000 Feb; 35(2):144-50. PubMed ID: 10611640
[TBL] [Abstract][Full Text] [Related]
12. Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines.
Mahé C; Bernhard M; Bobirnac I; Keser C; Loetscher E; Feuerbach D; Dev KK; Schoeffter P
Br J Pharmacol; 2004 Oct; 143(3):404-10. PubMed ID: 15339860
[TBL] [Abstract][Full Text] [Related]
13. Functional interactions between native Gs-coupled 5-HT receptors in HEK-293 cells and the heterologously expressed serotonin transporter.
Johnson MS; Lutz EM; Firbank S; Holland PJ; Mitchell R
Cell Signal; 2003 Aug; 15(8):803-11. PubMed ID: 12781873
[TBL] [Abstract][Full Text] [Related]
14. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
[TBL] [Abstract][Full Text] [Related]
15. Different efficacy of specific agonists at 5-HT3 receptor splice variants: the role of the extra six amino acid segment.
Niemeyer MI; Lummis SC
Br J Pharmacol; 1998 Feb; 123(4):661-6. PubMed ID: 9517385
[TBL] [Abstract][Full Text] [Related]
16. Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor.
Purohit A; Herrick-Davis K; Teitler M
Synapse; 2003 Mar; 47(3):218-24. PubMed ID: 12494404
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution of the human 5-HT(1D) receptor-G-protein coupling: evidence for constitutive activity and multiple receptor conformations.
Brys R; Josson K; Castelli MP; Jurzak M; Lijnen P; Gommeren W; Leysen JE
Mol Pharmacol; 2000 Jun; 57(6):1132-41. PubMed ID: 10825383
[TBL] [Abstract][Full Text] [Related]
18. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
[TBL] [Abstract][Full Text] [Related]
19. [3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum.
Hemedah M; Coupar IM; Mitchelson FJ
Br J Pharmacol; 1999 Jan; 126(1):179-88. PubMed ID: 10051134
[TBL] [Abstract][Full Text] [Related]
20. Dimethyl sulfoxide: an antagonist in scintillation proximity assay [(35)S]-GTPgammaS binding to rat 5-HT(6) receptor cloned in HEK-293 cells?
Mereghetti I; Cagnotto A; Mennini T
J Neurosci Methods; 2007 Mar; 160(2):251-5. PubMed ID: 17049618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]